The collaboration will leverage the firms' technologies to identify patients most likely to develop pancreatic cancer and to detect the cancer in the earliest stage.
In Nature this week: genomic characterization of pancreatic neuroendocrine tumors, and more.
Researchers showed it could differentiate pancreatic cancer cases from controls with high sensitivity, and believe it could work similarly for other cancers or in infectious disease.
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
The deal adds another major academic medical center to Tempus' roster of clients in the Great Lakes region.
The firm will sell 855,000 shares of its common stock to three investors. It will also sell warrants to the same investors.
Caris will be on the lookout for pancreatic cancer patients with low DNA mismatch repair protein expression.
The results indicate that while blood-based assays can be useful, tissue biopsies should remain the gold standard when available, said one of the study authors.
The research team established that its model can be used to determine the optimal dose of radiation therapy for individual patients.
The study, called Panfam-1, will analyze 1,000 individuals at high risk of familial pancreatic cancer over three years using the company's antibody array test.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.